Adverse events following the first, second and third doses of a COVID-19 vaccine in hemodialysis patients

Author:

Pai Mei-Fen12,Tung Kuei-Ting1,Hsu Shih-Ping123,Peng Yu-Sen145,Lin Wan-Yu6,Yang Ju-Yeh127,Wu Hon-Yen128,Chiu Yen-Ling129,Shu Kai-Hsiang12,Tsai Wan-Chuan17

Affiliation:

1. Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan

2. Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei City, Taiwan

3. School of Life Science, National Taiwan Normal University, Taipei City, Taiwan

4. Department of Applied Cosmetology, Lee-Ming Institute of Technology, New Taipei City, Taiwan

5. Department of Electrical Engineering, Yuan Ze University, Taoyuan City, Taiwan

6. Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei City, Taiwan

7. Center for General Education, Lee-Ming Institute of Technology, New Taipei City, Taiwan

8. Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei City, Taiwan

9. Graduate Program in Biomedical Informatics, Yuan Ze University, Taoyuan City, Taiwan

Funder

Far Eastern Memorial Hospital

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Reference28 articles.

1. Johns Hopkins University Coronavirus Resource Center. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. 2021. Accessed on 3 September 2022 https://coronavirus.jhu.edu/map.html.

2. National Center for High-performance Computing: COVID-19 Global Dashboard by Taiwan. Accessed on 3 September 2022. https://covid-19.nchc.org.tw/dt_005-covidTable_taiwan.php.

3. Electronic health record analysis identifies kidney disease as the leading risk factor for hospitalization in confirmed COVID-19 patients

4. Factors associated with COVID-19-related death using OpenSAFELY

5. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3